Literature DB >> 17895288

Effect of liver fat on insulin clearance.

Anna Kotronen1, Satu Vehkavaara, Anneli Seppälä-Lindroos, Robert Bergholm, Hannele Yki-Järvinen.   

Abstract

A fatty liver is associated with fasting hyperinsulinemia, which could reflect either impaired insulin clearance or hepatic insulin action. We determined the effect of liver fat on insulin clearance and hepatic insulin sensitivity in 80 nondiabetic subjects [age 43 +/- 1 yr, body mass index (BMI) 26.3 +/- 0.5 kg/m(2)]. Insulin clearance and hepatic insulin resistance were measured by the euglycemic hyperinsulinemic (insulin infusion rate 0.3 mU.kg(-1).min(-1) for 240 min) clamp technique combined with the infusion of [3-(3)H]glucose and liver fat by proton magnetic resonance spectroscopy. During hyperinsulinemia, both serum insulin concentrations and increments above basal remained approximately 40% higher (P < 0.0001) in the high (15.0 +/- 1.5%) compared with the low (1.8 +/- 0.2%) liver fat group, independent of age, sex, and BMI. Insulin clearance (ml.kg fat free mass(-1).min(-1)) was inversely related to liver fat content (r = -0.52, P < 0.0001), independent of age, sex, and BMI (r = -0.37, P = 0.001). The variation in insulin clearance due to that in liver fat (range 0-41%) explained on the average 27% of the variation in fasting serum (fS)-insulin concentrations. The contribution of impaired insulin clearance to fS-insulin concentrations increased as a function of liver fat. This implies that indirect indexes of insulin sensitivity, such as homeostatic model assessment, overestimate insulin resistance in subjects with high liver fat content. Liver fat content correlated significantly with fS-insulin concentrations adjusted for insulin clearance (r = 0.43, P < 0.0001) and with directly measured hepatic insulin sensitivity (r = -0.40, P = 0.0002). We conclude that increased liver fat is associated with both impaired insulin clearance and hepatic insulin resistance. Hepatic insulin sensitivity associates with liver fat content, independent of insulin clearance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17895288     DOI: 10.1152/ajpendo.00444.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  75 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Chronic Exposure to Excess Nutrients Left-shifts the Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic β-Cells.

Authors:  Karel A Erion; Charles A Berdan; Nathan E Burritt; Barbara E Corkey; Jude T Deeney
Journal:  J Biol Chem       Date:  2015-05-01       Impact factor: 5.157

3.  Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery.

Authors:  Guilherme M Campos; Charlotte Rabl; Peter J Havel; Madhu Rao; Jean-Marc Schwarz; Morris Schambelan; Kathleen Mulligan
Journal:  Surg Obes Relat Dis       Date:  2013-07-20       Impact factor: 4.734

Review 4.  NAFLD/NASH in patients with type 2 diabetes and related treatment options.

Authors:  M G Radaelli; F Martucci; S Perra; S Accornero; G Castoldi; G Lattuada; G Manzoni; G Perseghin
Journal:  J Endocrinol Invest       Date:  2017-11-30       Impact factor: 4.256

Review 5.  Hypobetalipoproteinemia and abetalipoproteinemia.

Authors:  Francine K Welty
Journal:  Curr Opin Lipidol       Date:  2014-06       Impact factor: 4.776

6.  Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes.

Authors:  Erikka Loftfield; Neal D Freedman; Gabriel Y Lai; Stephanie J Weinstein; Katherine A McGlynn; Philip R Taylor; Satu Männistö; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Prev Res (Phila)       Date:  2016-08-29

7.  Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.

Authors:  Jonathan Montomoli; Peter Holland-Fischer; Giampaolo Bianchi; Henning Grønbaek; Hendrik Vilstrup; Giulio Marchesini; Marco Zoli
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

8.  Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea.

Authors:  Craig L Phillips; Brendon J Yee; Mike I Trenell; John S Magnussen; David Wang; Dev Banerjee; Norbert Berend; Ronald R Grunstein
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

9.  Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Authors:  James E Everhart; Anna S Lok; Hae-Young Kim; Timothy R Morgan; Karen L Lindsay; Raymond T Chung; Herbert L Bonkovsky; Marc G Ghany
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

Review 10.  The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  Lipids Health Dis       Date:  2010-04-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.